Protagenic Therapeutics Inc PTIX
$0.74 $0.56 (43.08%) 1D
Last Updated: Jan 02, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
PTIX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Protagenic Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Protagenic Therapeutics Inc. Stock Analysis PTIX
United States Health Care Nano Cap Protagenic Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The firm has approximately six drug candidates targeting stress-related and CNS disorders, including treatments for obesity and metabolic disorders. The firm's pipeline includes PT-00114 in Phase I/IIa and five preclinical assets including PHYX-001, cannabinoid-based compounds, and modified stilbenoid assets. The PHYX-001 is a potassium channel modulator with a mechanism similar to XEN1101 and BHV-7000. The firm's cannabinoid assets include multiple cannabinoid-based compounds with composition-of-matter IP; potential in CNS, cardiometabolic, and other indications. The firm's cannabinoid assets also include a molecule with potential in the obesity, metabolic dysfunction sector, where the GLP-1 agonists have become medications. Its modified stilbenoid assets include modified stilbenoid compounds with composition-of-matter IP and anticonvulsant activity in preclinical models.
Protagenic Therapeutics Inc (PTIX) Chart
Financial Metrics & Statements of Protagenic Therapeutics Inc (PTIX)
FAQ's for Protagenic Therapeutics Inc (PTIX)
- As of August 2026, Protagenic Therapeutics Inc PTIX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Protagenic Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Protagenic Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Protagenic Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Protagenic Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Protagenic Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Protagenic Therapeutics Inc (PTIX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
